To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.
Bill journey · stage 2 of 5
Under committee review
What it does
A plain-language summary from the Congressional Research Service isn’t available yet for this bill. CRS summaries are typically posted within a few weeks of introduction.
What just happenedDec 17, 2024
Referred to the Subcommittee on Health.
Who’s behind it
- Introduced in HouseJan 31, 2024
- Dec 17, 2024Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Jan 31, 2024IntroReferralH11100
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Ways and Means Committee - Jan 31, 2024IntroReferralH11100
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Energy and Commerce Committee - Jan 31, 2024IntroReferralIntro-H
Introduced in House
- Jan 31, 2024IntroReferral1000
Introduced in House